Skip to main content
. 2022 Jun 9;12(12):1507. doi: 10.3390/ani12121507

Table 1.

Summary of signalment variables, presenting signs, and follow up information by treatment outcome group.

Information Rate
(n = 814)
Variable Overall
(n = 814)
Food Responsive
(n = 93)
Immunosuppressant Responsive
(n = 449)
Antibiotic Responsive
(n = 9)
Non Responsive
(n = 42)
Non Classified
(n = 221)
Study population 814/814 Sex (male/female) 463/351 52/41 246/203 6/3 23/19 136/85
113/814 Median BCS (1- 9/9) 4 (3–5) 4 (4–5) 4 (4–5) 4(4) 3 (3–4) 4 (3–4)
702//814 Median body weight (kg) 11.1 (6.5–25.9) 12.3 (6.4–27.6) 10.0 (6.3–23.7) 9.0 (6.2–14.1) 12.2 (7.6–30.2) 15.3 (7.5–28.9)
814/814 Median age at first visit (years) 3.8 (1.8–6.7) 3.8 (1.5–6.0) 3.7 (1.8–6.6) 4.1 (0.8–8.1) 5.0 (3.5–9.1) 3.9 (1.9–6.8)
814/814 Median age at last visit (years) 7.6 (4.8–10) 7.5 (4.8–9.3) 7.9 (5.5–10.6) 8.0 (2.5–12.8) 6.4 (3.7–9.1) 7.0 (4.2–9.5)
251/814 Median age at death (years) 9.2 (6.5–11.5) 8.9 (6.9–10.8) 10.3 (7.5–12.4) 11.3 (7.9–14.8) 6.6 (3.8–9.2) 8.8 (6.6–11.2)
814/814 Median time of follow up (years) 2.8 (0.9–4.6) 3.1 (1.1–4.5) 3.3 (1.5–5.2) 3.3 (1.7–4.3) 0.3 (0.1–0.7) 2.1 (0.4–3.6)
244/814 Euthanasia because of CE (yes/no) 116/128 3/9 42/82 1/1 41/1 29/35
Presenting signs 759/814 Vomiting (yes/no) 598/161 64/25 350/71 5/4 29/8 150/53
764/814 Diarrhea (yes/no) 574/190 67/25 298/115 8/1 35/5 166/44
503/814 Anorexia (yes/no) 282/221 33/32 157/108 2/6 21/10 69/65
269/814 Weight loss (yes/no) 184/85 14/14 93/47 1/1 22/2 54/21
469/814 Activity (decreased/normal) 247/222 29/29 124/114 1/5 21/13 72/61
764/814 Hematochezia (yes/no) 31/733 5/87 16/398 0/9 2/38 8/201
67/814 Stool frequency
(increased/normal)
41/26 8/6 17/10 2/0 3/1 11/9
250/814 Pruritus (yes/no) 205/45 17/12 122/17 2/0 6/3 58/13